Member access

4-Traders Homepage  >  Shares  >  NATIONAL STOCK EXCHANGE OF INDIA  >  GlaxoSmithKline Pharmaceuticals Limited    GLAXO   INE159A01016

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
03/26/2015 03/27/2015 03/30/2015 03/31/2015 04/01/2015 Date
3285(c) 3275(c) 3269.95(c) 3460(c) 3342.05 Last
8 048 16 217 17 151 54 614 22 876 Volume
-0.42% -0.30% -0.15% +5.81% -3.41% Change
More quotes
Financials ( INR)
Sales 2015 32 944 M
EBIT 2015 6 566 M
Net income 2015 4 763 M
Finance 2015 20 689 M
Yield 2015 1,79%
Sales 2016 -
EBIT 2016 -
Net income 2016 -
Debt 2016 -
Yield 2016 -
PER 2015 60,95
PER 2016 -
Capi. / Sales 2015 8,18x
Capi. / Sales 2016 -
Capitalization 290 163 M
More Financials
Company
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals.The company's product portfolio includes prescription medicines and vaccines.Its prescription medicines range across therapeutic areas such as anti-infective, dermatology,... 
Sector
Pharmaceuticals
Calendar
04/28Earnings Release
More about the company
Surperformance© ratings of GlaxoSmithKline Pharmaceut
Trading Rating : - Investor Rating :
More Ratings
Latest news on GLAXOSMITHKLINE PHARMACEUT
03/30 Glaxo Reaches Agreement With UK Government For Meningitis B Vaccine
03/27 GLAXOSMITHKLINE : The Law Office of Melinda J. Helbock, A.P.C. Announces That It..
03/27 GLAXOSMITHKLINE : The Law Office of Melinda J. Helbock, A.P.C. Announces That It..
03/26 AstraZeneca, Glaxo Sign Up For 100,000 Genomes Project Consortium
03/26 GLAXOSMITHKLINE : Glaxo Gets Approval For Encruse Ellipta, Two Other Products In..
03/19 GLAXOSMITHKLINE PHARMACEUTICALS : FDA panel backs Glaxo inhaler for adults, not ..
03/17 GLAXOSMITHKLINE : Glaxo Starts Phase III Programme For Retosiban In Premature Bi..
03/13 PRESS : J&J Sues Glaxo Over False Advertising Claims - Reuters
More news
Sector news : Pharmaceuticals - NEC
12:18p ASTRAZENECA : fourth quarter and full year results 2014
12:09p MERCK KGAA : Serono and MMV Sign Agreement to Develop Potential Antimalarial The..
12:08p VALEANT PHARMACEUTICALS INTL : completes $11.11 billion buyout of Salix
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart GLAXOSMITHKLINE PHARMACEUT
Duration : Period :
GlaxoSmithKline Pharmaceut Technical Analysis Chart | GLAXO | INE159A01016 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF